story of the week
Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer: MONARCH 2
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2- Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy
J. Clin. Oncol 2017 Jun 03;[EPub Ahead of Print], GW Sledge, M Toi, P Neven, J Sohn, K Inoue, X Pivot, O Burdaeva, M Okera, N Masuda, PA Kaufman, H Koh, EM Grischke, M Frenzel, Y Lin, S Barriga, IC Smith, N Bourayou, A Llombart-CussacFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.